This new website provides everyone involved with patients with heart failure with the necessary information and practical points of attention. Good education and cooperation between primary and secondary care are crucial. The care pathway was developed by the Belgian Heart Failure Working Group (BWGHF) and is supported by Domus Medica.

From 1 September 2024, mavacamten (Camzyos) will be reimbursed in Belgium for the treatment of obstructive hypertrophic cardiomyopathy. In hypertrophic cardiomyopathy, there is excessive growth and overactivity of myocytes. Among other things, the protein myosin is overactive. This causes increased contractility and reduced relaxation of the myocytes. In some of these patients, this leads to […]

HFA European Heart Failure Association congress 2025, Belgrade & Online, 17 - 20 May https://www.escardio.org/Congresses-Events/Heart-Failure/About-the-congress

This year’s theme, “Stunning Advances in Cardiology: Bridging Science and Patient Care” commemorates the 50th anniversary of the groundbreaking discovery of myocardial stunning by Belgian scientist and cardiologist Guy Heyndrickx.  https://www.bscardio.be/congress/congress-2025/